FDA — authorised 26 December 1990
- Application: NDA019926
- Marketing authorisation holder: EISAI INC
- Local brand name: HEXALEN
- Indication: CAPSULE — ORAL
- Status: approved
FDA authorised Hexalen on 26 December 1990
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 26 December 1990; FDA has authorised it.
EISAI INC holds the US marketing authorisation.